BioCentury
ARTICLE | Finance

Expect more company creation by BGV with its €105M fourth fund

Dutch VC BioGeneration Ventures expects to create half of the European start-ups backed by new fund

June 24, 2020 10:21 PM UTC

BioGeneration Ventures is the latest in a string of European early-stage VCs raising upsized funds that give them the ability to commit more capital to portfolio companies and retain larger stakes longer. The firm also expects to increase the number of companies it creates, the firm’s Edward van Wezel told BioCentury.

The Dutch VC closed BGV IV at €105 million ($117.7 million), more than its €100 million target and its €82 million vintage 2017 third fund...

BCIQ Company Profiles

BioGeneration Ventures